Sign in

    Ning Jia

    Research Analyst at Century Management

    Ning Jia's questions to Vivani Medical (VANI) leadership

    Ning Jia's questions to Vivani Medical (VANI) leadership • Q4 2016

    Question

    Ning Jia from Century Management asked about the competitive threat from eSight, questioning its market overlap with the Argus II for better-sighted patients and the future Orion device. She also inquired about the company's patient outreach strategy, asking if radio was the main channel and why social media wasn't more heavily utilized.

    Answer

    Chairman Dr. Robert Greenberg explained that eSight is a non-reimbursable, low-vision aid that enhances, not restores, vision, making it a complementary technology with no foreseeable market overlap with Argus II or Orion. President and CEO Will McGuire detailed the patient outreach process, confirming radio ads are the primary and most cost-effective channel for generating qualified patient leads, though they also use social media and work with organizations like the Foundation for Fighting Blindness.

    Ask Fintool Equity Research AI